Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Anatolian Journal of Cardiology|May 8, 2019
Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in TURKEY: inferences from GARFIELD-AF registryBegüm Sayın, Sercan Okutucu, Mehmet Birhan Yılmaz, et al.
Open Heart|July 2, 2024
Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AFJelle C L Himmelreich, Saverio Virdone, John Camm, et al.
Lancet (London, England)|August 19, 2008
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialJohannes F E Mann, Roland E Schmieder, Matthew McQueen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 11, 2019
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AFShinichi Goto, Shinya Goto, Karen S Pieper, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 14, 2015
The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial resultsUlrich Schotten, Stephane Hatem, Ursula Ravens, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 23, 2021
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillationKeith A A Fox, Saverio Virdone, Karen S Pieper, et al.
BMJ Open|December 24, 2017
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulationKeith A A Fox, Joseph E Lucas, Karen S Pieper, et al.
Circulation. Cardiovascular Quality and Outcomes|February 26, 2015
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial FibrillationGregory Y H Lip, Sophie K Rushton-Smith, Samuel Z Goldhaber, et al.
Lancet (London, England)|August 20, 2013
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trialStephen D Wiviott, Harvey D White, E Magnus Ohman, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 9, 2017
Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)Gregory Y H Lip, Antonio Coca, Thomas Kahan, et al.
Pageof 20